Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 5 maj 2020NewsHumanCOVID-19 COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines 4 maj 2020Press releaseHumanCOVID-19MedicinesResearch and developmentVaccines Regulatory flexibility to ensure availability of veterinary medicines during COVID-19 pandemic 4 maj 2020NewsVeterinaryCOVID-19Regulatory and procedural guidanceMedicine shortages EMA starts rolling review of remdesivir for COVID-19 30 april 2020Press releaseHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020 30 april 2020NewsHumanMedicinesReferrals EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine 30 april 2020Press releaseHumanPharmacovigilanceReferrals Risks of Picato for actinic keratosis outweigh benefits 30 april 2020Press releaseHumanMedicinesReferrals Suspension of ranitidine medicines in the EU 30 april 2020Press releaseHumanPharmacovigilanceQuality of medicinesReferrals First triple combination therapy for asthma with optional electronic sensor 30 april 2020Press releaseHumanMedicines EU actions to support availability of medicines during COVID-19 pandemic – update #4 30 april 2020Press releaseHumanCOVID-19Medicine shortages 1 … 83 84 85 86 87 Page 87 of 380 88 89 90 91 … 380
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 5 maj 2020NewsHumanCOVID-19
COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines 4 maj 2020Press releaseHumanCOVID-19MedicinesResearch and developmentVaccines
Regulatory flexibility to ensure availability of veterinary medicines during COVID-19 pandemic 4 maj 2020NewsVeterinaryCOVID-19Regulatory and procedural guidanceMedicine shortages
EMA starts rolling review of remdesivir for COVID-19 30 april 2020Press releaseHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020 30 april 2020NewsHumanMedicinesReferrals
EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine 30 april 2020Press releaseHumanPharmacovigilanceReferrals
Risks of Picato for actinic keratosis outweigh benefits 30 april 2020Press releaseHumanMedicinesReferrals
Suspension of ranitidine medicines in the EU 30 april 2020Press releaseHumanPharmacovigilanceQuality of medicinesReferrals
First triple combination therapy for asthma with optional electronic sensor 30 april 2020Press releaseHumanMedicines
EU actions to support availability of medicines during COVID-19 pandemic – update #4 30 april 2020Press releaseHumanCOVID-19Medicine shortages